Nuvectis Pharma, Inc. (NASDAQ:NVCT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kenneth Hoberman Other companies: TG Therapeutics, Inc. (Chief Operating Officer and Corporate Secretary · Since at least Jun 26, 2018); Stemline Therapeutics Inc (Chief Operating Officer · Dec 15, 2017 – Jun 10, 2020 · Past) | Director · Since at least Feb 8, 2022 |
| Ron Bentsur Other companies: Beyond Air, Inc. (Director · Jul 27, 2020 – Nov 22, 2024 · Past); Stemline Therapeutics Inc (Director · Jun 25, 2019 – Jun 10, 2020 · Past) | Chairman & CEO, Director · Since at least Feb 4, 2022 |
| James F Oliviero III Other companies: Checkpoint Therapeutics Inc (CEO, President and Director, Director · Since at least Apr 2, 2025) | Director · Since at least Jun 12, 2025 |
| Uri Ben-or Other companies: Scinai Immunotherapeutics Ltd. (Director · Since at least Jan 1, 2023) | Int. Principal Financial Off. · Feb 8, 2022 – Feb 8, 2022 · Past |
| Enrique Poradosu | Executive Vice President, Chief Scientific and Business Officer · Since at least Jan 3, 2024 |
| James F. Oliviero | Director · Since at least Jun 12, 2026 |
| Juan Sanchez | Director · Since at least Sep 25, 2025 |
| Ken Hoberman | Director · Since at least Jun 12, 2026 |
| Matthew L. Kaplan | Director · Since at least Jun 12, 2026 |
| Michael J Carson | Vice President, Finance · Since at least Mar 18, 2022 |
| Ron Bentsur | Chairman, Chief Executive Officer and President · Since at least Jul 1, 2026 |
| Shay Shemesh | Chief Dev. & Ops. Officer · Since at least Jan 6, 2026 |